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Mr. WALGREN. Thank you very much. It is very interesting. 
All right, let us turn to Mr. Pearsall. 
STATEMENT OF DUANE PEARSALL, CHAIRMAN, COLORADO AS-
SOCIATION OF COMMERCE AND INDUSTRY, AND GENERAL 
PARTNER, COLUMBINE VENTURE MANAGEMENT INC. 
Mr. PEARSALL. Thank you, Mr. Chairman. I, too, am very privi-
leged to appear before this hearing and especially, Congressman 
Skaggs, whose career I have watched and participated in for a long 
time. 
I think this hearing process is a very valuable way to look at this 
major problem involving a major amount of tax resources going 
into research and development. 
I apologize that I do not have written testimony. This is entirely 
oral. I did not have an opportunity to prepare it. 
Mr. WALGREN. No apology is necessary. 
Mr. PEARSALL. Let me start at the beginning. 
My name is Duane Pearsall, and I am a general partner of. Col-
umbine Venture Fund, a typical institutional venture fund. I am 
also chairman this year of CACI. 
I might point out that my background and reputation have 
always been in small business, and for CACI to use a small busi-
ness person or have a small business person as chairman, demon-
strates that our business organization in the state is broad based. 
Mr. WALGREN. CACI is what again? 
Mr. PEARSALL. CACI is the Colorado Association of Commerce 
and Industry, in effect, the state Chamber of Commerce. 
I wanted to appear at this hearing because I see the direction of 
our country relative to our loss in technology leadership being a 
very serious problem. And before making a statement, let me just 
identify where I come from and the perspective that I have so that 
you can place it in context. 
I have been, as I said before, a small businessman for 25 years, 
and I developed the home smoke detector back in 1970. It was very 
successful, and as a result of that company I was named small busi-
ness person of the year in 1976 nationally. As a result of that, I 
was appointed to a number of committees, beginning with the 
Equity Capital Committee of the SBA in 1976. 
The small business cause became an obsession with me for the 
next four years, and I spent about 90 percent of my time running 
back and forth to Washington. I testified before the U.S. Chamber, 
before the FTC, and before Senate and House committees on the 
general subject of stimulation of the economy through small busi-
ness, and the inadvertent impediments to small business that 
exists in our national policy, not by intent but by inadvertent 
action. 
In 1978, I served on an advisory committee for industrial innova-
tion and technology, which was to be a policy review committee in-
volving about 95 Fortune 500 key personalities, usually the chair-
man or the president of those companies. Five members of that 
were small business people. 
Simultaneously with the development of that committee, the 
SBA, through Mr. Milt Stuart, then chief counsel for advocacy, de-
1 
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veloped a small business high tech committee. That committee 
became a part of the ultimate report, though it was not part of the 
formal committee, which was a compliment to the Department of 
Commerce for incorporating it. 
Out of that small business committee came the seeds of the de-
velopment of what is known now as the Small Business Innovation 
Research Act of 1982. That act, in my view, has created more com-
mercialized technology than I have seen visible from all of the gov-
ernment labs. This is not an indictment of the government labs. I 
have not seen signs that the government labs might produce devel-
opments that are commercially viable, and I am concerned with 
this. 
At ten o'clock last night, I asked the chancellor of the University 
of Denver, Dr. Dwight Smith, if I could paraphrase him in this 
hearing this morning. He reported, in a conference on superconduc-
tivity a few months ago, jointly sponsored by the Japanese Export 
Trading Office and the Colorado School of Mines, a key statement. 
At the end of his report he stated that the government should look 
at the $12 billion currently going into government labs, and look at 
the meaning to this country in terms of output, and consider di-
verting a large portion of that into university research where it is 
more accessible to commercial viability, or to commercialization. 
I think he is right on. That editorial appeared in the Denver Post 
a few months ago, and I saw very little comment to it. I think that 
it is time that we look at the entire $50 billion of government re-
search, and as he said, the $12 billion to government labs, and look 
to see if that cannot be more effectively used in university re-
search. 
Let me spend a minute on the venture capital industry, if I 
might. Now, I come from a bias. Venture capital industry had only 
about a hundred million dollars invested in small portfolio compa-
nies in 197 4. Today, there are over $25 billion. That is not frivolous 
investment. Those investments are made through institutional 
funds and SBIC funds that are a program of the Small Business 
Administration. That pool now is over $25 billion, and there is 
about $3.5 billion per year of new money going into the venture 
capital industry. 
I consider the venture industry in the United States to be Ameri-
ca's secret economic weapon, and very few people recognize it as 
such. It affects the State of Colorado rather dramatically. Colorado 
currently ranks seventh in the amount of funds going into small, 
99 percent high tech businesses in the State of Colorado. That 
money is going into usable commercial ventures because the profit 
motive drives it. 
Now, Colorado ranked fourth or fifth for five consecutive years. 
Only in 1987 did it become superseded by the States of Connecticut 
and Illinois. In looking into why we slipped in our position, you 
have to attribute part of the reason to state initiated seed capital 
funds in those two states. As a result, CACI is supporting a bill 
which has passed, as of day before yesterday, the Senate House Af-
fairs and Labor Committee of the state. This bill establishes at 
least two small seed capital funds with the state acting as a facili-
tator. The funds will be managed by the private sector who will use 
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the profit motive, and the funds will receive state loans which 
match equity investments from the private sector. 
The first distribution of funds will go back to retire the state 
loan, and the private sector will remain at ultimate risk. We 
expect to attract private capital into it because they will get an 
equity gain of twice their investment. 
This raises the issue of capital gains. If I could put in a plug for 
restoring capital gains, I would like to do it. 
Let me amplify that venture capital is America's secret economic 
weapon. Look at Japan, and see if you can duplicate the venture 
capital process there. I know it intimately because the largest ven-
ture capital company in Japan is an investor in our fund. 
You see in Japan, individuals are taught loyalty and diligence 
from the day they are born. They go to work for life. The last thing 
in their mind is separating themselves from an industry to start a 
company on their own. And, yet, that is the mechanism that feeds 
the venture capital industry in the United States. 
So it is unlikely in the next couple of generations that Japan will 
establish a venture capital community that even compares to a 
small extent with the United States. 
Mr. WALGREN. Let me understand that again. 
In Japan, you have employees loyal for life. 
Mr. PEARSALL. Yes. 
Mr. WALGREN. And that is in sharp contrast to our system. 
Mr. PEARSALL. Exactly. 
Mr. WALGREN. And is that good or bad? 
Mr. PEARSALL. I think it is excellent. In the United States, the 
person is free to leave a major corporation with an idea to start a 
company. 
Mr. WALGREN. And this you see as a hindrance to Japan? 
Mr. PEARSALL. Absolutely. 
Mr. WALGREN. Okay, I just wondered how you were approaching 
it. 
Mr. PEARSALL. Take Europe or take Switzerland specifically as 
an example. It is not a viable mechanism there. In Switzerland, the 
shame of losing a family's fortune in a business enterprise, and 
leaving debt, is a blight on the family. The pressure against start-
ing a business as a result is far more severe in Switzerland. 
Here, we feel failure is a contribution to the background of an 
individual. We have invested in people that have been failures 
before, and we say in a very rational way, they have learned a lot 
about what not to do. 
So United States is unique in this basic structure and the 
thought process of people, and that causes the venture capital in- ~ 
dustry to survive. Now, we invest in institutional funds that go into 
high technology businesses. But in my view, this act, the Steven-
son-Wydler Act, has been totally invisible. 
In attending association meetings, we see a number of high tech 
companies displaying their potential. They are constantly in discus-
sions with other venture capitalists throughout the United States. 
It is a big fraternity. We exchange information, we co-venture all 
the time. It is an immense resource that the government currently 
is not using. In talking to all those people, I have yet to hear of a 
·-. 
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company getting help from a government lab or getting technology 
out of a government lab. . 
To close, let me just emphasize something in the SBIR program, 
Small Business Innovative Research. Colorado ranks seventh in the 
amount of awards granted to companies, demonstrating that Colo-
rado is a high tech center. Colorado is also a high tech center for 
the management of venture capital funds. There is more here than 
there is between Chicago and California. 
But the SBIR program now involves 1.25 percent set aside of 
R&D funds for all government agencies that have a budget in 
excess of $100 million. To my way of thinking and what I have seen 
come out of it so far, and we invest in a number of SBIR compa-
nies, that has been a very valuable program. If I could put in one 
more plug, Congress should consider increasing that set aside from 
1.25 to 3 percent minimum. It has been a very effective program. I 
believe the agencies will react positively as well as the venture cap-
ital community. 
Mr. WALGREN. Let me be sure that I understand. 
The one and a quarter set aside goes both for research efforts 
that are responding to a subject area request by the lab, and also 
fund the lab in response to a suggestion by the private sector; is 
that right? Both things occur; is that correct? 
Mr. PEARSALL. The mechanism is that each agency once a year 
puts out a manual with a list of technologies that they would be 
interested in that have commercial viability. Anyone may apply for 
a Phase 1 grant to demonstrate valid technology. In doing that, 
they get a $50,000 grant, and six months to perform that task. At 
the end of six months, then they can apply for a Phase 2 grant, 
and that process usually takes another six months. Being awarded 
a Phase 2 grant, they receive up to $500,000 and two years to devel-
op that technology. But the basis of that Phase 2 grant is its com-
mercial potential. So that mechanism of government is the only 
thing I have seen that orients research grants directly to commer-
cial potential. 
Mr. WALGREN. In the eyes of the federal agency. 
Mr. PEARSALL. Yes, that is correct. 
Mr. WALGREN. In other words, they are the one that is judging 
whether something is commercially viable at that point. 
Mr. PEARSALL. That is correct. 
Mr. WALGREN. Interesting. And it is a $500,000 cap at that point? 
Mr. PEARSALL. It is up to $500,000 and two years to do Phase 2. 
Phase 3 requires private funding to move the company into the 
commercial marketplace. 
In our portfolio of 31 companies, I would judge that we have at 
least six companies that have at least one Phase 2 award, and it is 
a resource for us for technology. Since the SBA tabulates these 
awards of all of the agencies, it gives us a great resource to follow. 
I do not have any constituency to worry about. I am not connect-
ed with a large corporation. I am not speaking for the business 
community. I am speaking as an individual. And I want to correct 
the governor on one thing. 
I am also on the advisory committee of CATI, and it started six 
years ago, and six of us spent a year raising the first money from 
the private industry to get the thing started and ultimately sold it 
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in pieces to the state legislature which now funds it. It is an excel-
lent program. CACI is strongly behind it. 
Mr. WALGREN. Well, thank you very much. We appreciate tha 
testimony. 
Dr. Stromberg. 
STATEMENT OF DR. ROBERT P. STROMBERG, REGIONAL COORDI-
NATOR, MID-CONTINENT REGION, FEDERAL LABORATORIES 
CONSORTIUM 
Dr. STROMBERG. Yes, sir. I also thank you for the opportunity to 
testify before you. My comments are primarily addressed, because 
of your request, to the Federal Laboratory Consortium, but I intend 
to follow up at the end with a few suggestions of ways in which we 
see barriers still present. 
As I say in the testimony, which I will not try to read, I would 
say to Mr. Pearsall that I think upon closer examination of the 
record of many of the federal labs, you will find that there are a 
fairly significant number of technologies flowing from the laborato-
ries. 
As an example, for a five-year period at our laboratory, which is 
one of the large ones, we did search through our labs to find out 
just exactly what kind of a record existed. We found that in that 
five-year period some 200 technologies were transferred to some 
900 companies. And I think your staff has seen the reports that de-
scribe that kind of transfer. 
So, we feel that there is a flow. It is publicized very little, so per-
haps that is one of the reasons he is not aware of it. 
It is definitely growing as time goes on now, too. I think through 
the actions of the national legislature, as there are now some seven 
or eight bills, starting with the Stevenson-Wydler, Bayh-Dole, and 
on down through the bill you passed in the fall of 1987. Each one of 
these has been in the right direction for moving the authority of 
management and dissemination of technology further down the 
federal chain, and delegating it to the federal laboratories. 
As a matter of fact, you covered all but a very small section of 
labs which unfortunately happens to include us. We are one of the 
types of laboratories that has been excluded from that legislation, 
of which I am sure your staff is well aware. 
But even with that, we have still been able to move things in 
those cases where there was not an absolute requirement for exclu-
sivity. However, the problem has been when there has been a re-
quirement for exclusivity before investment would be made. 
The Federal Laboratory Consortium was started because of some-
thing that was recognized many years ago by people in federal labs 
when we had a very outrageous condition. A person, for instance, 
like Mr. Pearsall, might call me at Sandia National Laboratories, 
and ask about our activities in bioscience and inquire if we could 
offer some technology. 
Without the Federal Laboratory Consortium and some sort of 
networking, the answer had to be, "Yes, Mr. Pearsall, we under-
stand your question. But our laboratory does not work in that area. 
Why do you not try one of the other 200 labs," a terribly outra-
geous answer to give to a person with a question like this. 
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So some 12 years ago people in these federal laboratories began 
to get together and try and form an informal network so they could 
make a referral and say to Mr. Pearsall, "Well, why do you not go 
talk to Dr. Jones at Los Alamos, or Dr. Smith at Bureau of Stand-
ards, because these people are working in that area." This is the 
germ of that idea that you have now supported last year with the 
bill that even gave us access to some funds to set up an electronic 
mail system and carry this on more efficiently. 
I think one of the other large functions of the Federal Lab Con-
sortium right now is due to the delegation of authority to these fed-
eral labs. We find almost every day a person at a new federal lab 
being given the assignment to take this problem on seriously as a 
full-time staff person and generate, in some cases, even additional 
staff. 
As those people then look around to see how to do this, they find 
they can go to a Federal Laboratory Consortium meeting and ex-
change information with those officers at those labs that have been 
in this business for awhile. We have a very active training program 
to try and help those people benefit from the experience of other 
members of this community of people trying to move technology 
out of the labs. 
Mr. WALGREN. Let me be sure folks in the back can hear. I do 
not know how good our microphones are in projecting this. Are you 
all able to hear? Maybe if you do pull that microphone in and 
speak directly into it, it will project. 
Let me invite those of you in the back who cannot hear to come 
down a little bit closer, and invite you to project towards that 
microphone as best you can. 
Dr. STROMBERG. I will try as best I can. 
The Federal Laboratory Consortium, in its organization, has 
broken the country into six districts. The reason I am here speak-
ing to you is because I am the Mid-Continent Regional Coordinator. 
I am the person trying to help emphasize the coordination and 
gathering of infor~ation from the federal laboratories in the 
center of the United States, starting with New Mexico, Texas and 
Louisiana on the south, and up through North Dakota and Mon-
tana on the north, a 15-state region in which Colorado would be 
just about a central state. 
Also in this area we have the chairman of the Federal Lab Con-
sortium, Gene Stark at Los Alamos Laboratory, so we are actively 
involved in it. And as I mentioned in my notes, I think Dana 
Moran at the Solar Research Institute and Al Taylor at the Fish 
and Wildlife Bureau within Colorado are also active members in 
the Federal Laboratory Consortium. 
As I have said before, we have operated in the past in a relative-
ly informal way in having meetings where we became acquainted 
with one another, and therefore could make referrals. We are 
gradually improving that process and are now setting up a re-
source directory of the federal laboratories where we will attempt 
to gather rather specific statements as to the areas that federal 
labs might be approached from a private commercial point of view 
to find technologies in their area. 
This is a growing movement within our laboratory. As I also 
mentioned, I would say that the training sessions that we conduct 
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are probably the other major one, because as I mentioned in the 
notes, we are surprised to find approximately 30 new people show-
ing up at each of our meetings. When we have our next meeting 
which will be in May, in Washington, D.C., I am sure there will be 
somewhere in the neighborhood of 25 or 30 new people at the Cap-
ital Holiday Inn. They will be there to find out just how this works. 
It is interesting, too, that having delegated to us the kind of au-
thority you have, representing the Federal Lab Consortium in Jan-
uary, I went to the Air Force Human Systems Laboratories in San 
Antonio. It was a very interesting experience to hear the uni-
formed Air Force officers asking very serious questions of an expe-
rienced licensing woman we brought to that meeting, because they 
now find this new assignment coming to them. That is, the assign-
ment of actually dealing on a business basis with the technologies 
that may come from that laboratory. So your legislation is having 
far-reaching effects. 
Unfortunately, though, our government agencies are huge. And 
because our government agencies are huge, it is a very slow process 
to go from the legislation passed in our Congress to the regulations 
that finally get all their t's crossed and all their i's dotted, and ac-
tually get down to the working level. 
I mentioned a couple examples of that. As of right now, the De-
partment of Defense is still working on its regulations based on 
your 1986 law. They are anxiously anticipated at the lower levels 
within the various services. It takes time for those things to move. 
In the agency that I am involved in, the Department of Energy, 
the 1984 law just reached its culmination this past year with many 
of the Department of Energy Labs' contracts being changed to re-
flect the 1984 law. So there are some large delays associated in a 
large system of government which tend to work to the detriment of 
these kinds of programs, and slow them down essentially. 
Mr. WALGREN. How do you estimate the impact of just pure size 
versus the failure of the administrators in those Executive Branch 
agencies to reach and move? 
Dr. STROMBERG. Within large agencies, there are large numbers 
of people who concur in new policy, and the process of moving 
through those many people is, in my mind, one of the large impedi-
ments. 
It is hard for me to evaluate that. As I said, though, in the notes, 
it is clear that there are still many, many people within the federal 
laboratories and in the federal agencies who feel that exclusivity is 
something that may result in an unfair advantage. This is some-
thing that Was a cult that was present for many years. I think 
many civil servant people have difficulty with that concept. Where-
as we recognize that our laboratory in many cases, without this po-
sition-and my venture capital friend here could speak to that elo-
quently-without this position, he will not invest his money and 
other people will not invest their money. They want to be sure that 
it will not-a short time after they market their product-suddenly 
be copied and duplicated and be brought forth by some other 
person to cut off their access to a larger market. So there is a cult 
that I have to admit I even shared five or six years ago probably 
more than I do today in that regard. 
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That came out in my second point here where I mention that 
this is still a practice of government procurement practices giving 
equal access to all. That has created a very strong tradition among 
governmental people that they should advertise and make public 
and make available to all. And it turns out, having been to licens-
ing executive society meetings, which I have gone to for course 
work, I find that those who handle licensing of technology in the 
commercial world clearly do not follow anything resembling the 
practices of government procurement. 
They make a deal with who they feel is the best commercial user 
of their technology, who will do the best job of commercializing it, 
because they will then benefit to the greatest extent in terms of 
royalties. So there is a different mindset here that is creeping over 
the country as a result of the pressure by your legislation, but it 
takes time. 
I want to come then to my final point, and say that if I were to 
make any one suggestion here this morning, I would make the sug-
gestion that you take a careful and complete and thorough look at 
the question of software. 
It has been badly neglected I think in this country. It is not rec-
ognized what dramatic value there is in it, and I would suggest to 
you that it is a form of intellectual property that is quite different 
than a patent. Software usually is the tool that makes the part 
rather than being the idea that is used to generate the part. 
I think within the agency that I come from, there is still a diffi-
culty for us in making specific exclusive arrangements in the ap-
propriate way that we would like with private companies. And I 
would suggest to you that it be a subject for very serious review 
through your legislative process. I think it has been overlooked too 
long as an extremely valuable source. 
I will give you one example. We are not in a position at our labo-
ratory to exclusively transfer software any under circumstance. 
The current practice is to distribute it through a central sales 
point. 
We recently had a case. We are, by the way, a laboratory that 
makes micro chips that are used by many other agencies. Because 
of some unusual circumstances, we actually manufacture a chip, 
believe it or not, very special chips. 
We took software from a commercial software house and modi-
fied it, and improved it to a significant extent. Then our staff 
people found that their friends at other companies in American in-
dustry wanted copies of that improvement. But we are in a difficult 
position because we can not make it available on any other basis 
but through a public release. 
We entered into an agreement with that software house so they 
would clean up our work on their software and supply us with the 
improved version. We were not able to promise them that we 
would not pass that on to their competitors. But even on that basis, 
they have given us access to about $2.5 million worth of the com-
pleted product. So that is an indication of the value of simply help-
ing this one company improve a software that we want to use in 
our little chip factory. 
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Had we been able to promise that by no means would this be 
transferred also to competitors, I am certain that that value would 
have been significantly higher to that company. 
Thank you very much. 
[The prepared statement of Dr. Stromberg follows:] 
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My name is Robert P. Stromberg. I was invited to testify on "how the FLC works, what the 
FLC has to offer in the Denver area, and what has been the FLC experience under the 
Federal Technology Act of 1986." 
My comments are personal, and not the official position of either the Federal Laboratory 
Consortium (FLC); my employer, Sandia National Laboratories, a Department of Energy 
prime contractor; or the Department of Energy. 
Technology transfer from federal laboratories has been on a steady increase in effectiveness 
over the last eight year.s, as its economic benefits are recognized. Also, a series of acts of 
·Congress and Executive Orders are forcing changes in attitudes in government a~encies and 
labs. Technology transfer is alive and well in the region. We estimate some 50 significant 
new technologies move from our lab each year. Last year Sandia transferred a major new 
technology to Kaman Sciences of Colorado Springs, along with three key employees. The 
new technology, called a high speed multichannel data recorder technology, 1s based on 
photonics. This is a technology for using light instead of electrons for obtaining large 
amounts of data at extremely high speed. Raman is using this technology to develop a new 
system for recording data With the increased autonomy now moving to labs, I'm sure you 
can expect a growth in the rate of new commercial activity based on lab technology. 
Unfortunately, our laboratory and others either operated by a large business, or funded by 
nuclear weapons money, are still excluded from the liberalizing legislation of the past eight 
years. 
A vital function of the FLC is to assist commercial interests in finding the government 
laboratory that can help them with a problem. By networking with other labs, the FLC can 
make referrals to all other federally-supported Jabs. Denver area businesses can use the FLC 
to find the right federal laboratory to help them with a problem, or offer them a new 
technology for commercial develo{lment. Our government has no formal ties across agencies 
to perform this task, and the FLC 1s working to fill this need. 
The Federal Laboratory Consortium was an unofficial organization for 12 years until 
Congress formally recognized us with provisions in the Technology Transfer Act of 1986. 
Funds that Con~ess recently gave us for five years are allowing us to expand our activities. 
We have an active training program, hold national meetings every six months, are organizing 
a more efficient way to locate specific technologies in the labs, and we have many other 
activities to promote transfer from government labs. 
The Federal Laboratory Consortium is divided into six regions based on geography. I 
represent the Mid-Continent Region, which includes 15 states from New Mexico, Texas, and 
Louisiana on the south, to Montana and North Dakota on the north. We have 18 active 
contacts in the region, including the FLC Chairman, Dr. Eugene Stark, at Los Alamos 
National Laboratory. At present, the facilities most actively supporting FLC in Colorado are 
the Solar Research Institute at Golden, with Mr. Dana Moran an elected member of the 
executive committee of FLC, and workshop organization by Mr. Alan R. Taylor of the Fish 
and Wildlife Service in Fort Collins. 
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In the past, the volunteer Fl.C members have worked in a rather informal way. A request to 
a member lab would be referred to other FLC members in other laboratories, based on 
personal kno' odge, and access to scientific specialists in several labs, who had a depth of 
knowledge of . •her workers in the field. 
Using funds provided by the new legislation, we are improving this system by obtaining 
detailed lists of active technology development at the various laboratories, and establishing a 
file of laboratory data called a "resource directory." As the resource directory becomes more 
complete, referrals will be more accurate. 
Other valuable training services of the Fl.C are presentations and private conversations at the 
meetings, where new technology transfer personnel at the laboratories can learn how to 
operate efficiently. Every meeting has perhaps 30 new persons in the "New Representative" 
workshop, a regular part of the meeting format. 
I assure you the Fl.C is moving ahead to increase the economic impact of federal 
laboratories. 
The charter for this hearing asks for information about barriers to transfer from federal Jabs. 
would list the following: 
I. Slow reaction of agencies to new laws and regulations. 
a. DOD is working in 1988 to implement regulations based on the 1986 law. 
b. DOE completed new laboratory contract modifications in 1987 to implement the 1984 
law. 
c. rm told by our FLC Washington Representative, Lee Rivers, that "most agencies are 
working on regulations to implement the 1986 law." 
2. Private firms ready to risk capital are discouraged by their inability to obtain exclusive 
licenses. 
a. Government procurement practices of equal access to all, therefore, no exclusive 
opportunity, is still a common point of view. 
b. The commercial reality that investors many times need exclusive control is still not 
widely accepted in government agencies. 
c. DOE nuclear and large company contract laboratories have not been included in 
legislation, therefore, cannot offer exclusive rights. 
3. Software management policies have not kept pace with the rapid rise in its importance. 
L Previous laws are cited as requiring universal dissemination. 
b. Sortware must be treated as another form of technology, and managed in a way similar 
to new methods now being implemented for other forms of federally-developed 
technology. 
Thank you for the invitation to testify. 
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Mr. WALGREN. Thank you very much. We appreciate that testi-
mony. 
Congressman Skaggs? 
Mr. SKAGGS. Thank you, Mr. Chairman. 
Let me make one administrative remark. I\.do not know whether 
all of the witnesses, both this panel and others that will be testify-
ing, were properly invited to the luncheon that will be held at the 
Brown Palace for all of you and the committee and committee staff 
at 1:30. If you did not get that invitation, I wanted to make sure 
you received it now, and hope if your day permits, you can join us 
down there. 
One of the things that might happen there on a small scale 
sounds like it also needs to happen on a large scale, which is to get 
the Mr. Strombergs of the world talking to the Mr. Pearsalls of the 
world, which is exactly one of the practical benefits to come out of 
a day like this. 
But it sounded as though there is, from your testimony, a signifi-
cant success story to be told which is valuable in its own right, but 
also because it can stimulate the imagination and interest of the 
venture capital community. And Mr. Pearsall observed that his col-
leagues represent a resource that the government simply has not 
taken adequate advantage of. 
And I just wanted to invite you two to talk to each other publicly 
for a minute about how we can effect that kind of linkage. 
Duane, do you want to lead off? 
Mr. PEARSALL. Well, you know, the critical element between re-
search and commercial product is somebody's judgment. And let 
me give you some numbers that throw a damper on the enthusiasm 
for taking technology out of universities or out of government labs. 
And these are national statistics. We have a very accurate bean 
counter in Massachusetts that keeps track of investments made by 
venture capital. Typically, when we receive a business plan, it is 
the considered judgment of an entrepreneur who has put a lot of 
his personal life's savings in to it. He believes that it is a good pro-
gram. When we get a hundred of those business plans, out of that 
we will take a second look at only 10 percent, and we will invest in 
only two. That is a national statistic. And I would submit that an 
idea coming out of the government lab might not have better credi-
bility for commercial viability than one of those business plans. 
Now the punch line is that after we have invested in 20 compa-
nies of that 2 percent, we find that 70 percent of our decisions were 
wrong. 
Now you put those two numbers together, and it is a very small 
percentage of technology that ultimately can find its way to a com-
mercial product. That is a damper on enthusiasm, but I do not 
think the analogy is that far off. 
Mr. SKAGGS. Well, it sounds as though that also plays off of what 
Dr. Seebass was saying; that what really makes it go are people 
with their talents moving from a lab, whether university, govern-
ment, whatever, and deciding to put their talent to work. 
Dr. SEEBASS. Yes, I think the principal and major difference be-
tween technology transfer from federal laboratories and from uni-
versities to the private sector is that we educate people and they 
carry technology with them. 
